Leveraging a pulsatile delivery platform to create a single-injection rabies vaccine
Tuesday, July 15, 2025
10:29 AM – 10:54 AM EDT
Introduction: Rabies is the deadliest viral disease with a nearly 100% fatality rate if untreated; however, post-exposure prophylaxis (PEP) consisting of a vaccine and rabies immune globulin lowers the fatality rate to < 1%. Unfortunately, this treatment requires up to four vaccine doses administered over up to four weeks. Consequently, many do not receive appropriate treatment, resulting in 60,000 deaths annually (1). Herein, we create a single-injection rabies vaccine by engineering antigen-loaded microparticles to release their payloads in discrete pulses that recapitulate a standard PEP dosing regimen.
Learning Objectives:
At the completion of this activity, participants will know
Understand how excipients improve protein stability through particle encapsulation and release.
Evaluate the effect polymer properties on release kinetics.